Background and Objectives Dyslipidemia is a modifiable major risk factor for coronary heart
disease. The objective of this study was to determine the prevalence of dyslipidemia among …

BACKGROUND: Dyslipidemia, which has been closely linked to pathophysiology of
cardiovascular diseases, is a key independent modifiable risk factor for cardiovascular …

The objective of this study was to estimate the prevalence of dyslipidemia as defined by
NCEP ATP III criteria in the Trabzon Region of Turkey and to determine its associations with …

Background Despite the importance of identifying and screening dyslipidemia to prevent
coronary artery diseases CAD (Coronary Artery Disease), little information is available on …

More than 80% cardiovascular disease (CVD) is preventable despite the fact that it is
currently the ultimate cause of disability in the world. Assessment of the nationwide …

Aims Dyslipidemia is a known risk factor for cardiovascular disease and is a leading cause
of mortality in developed and developing countries. This study was aimed to determine the …

Background. Dyslipidemia is one of the major modifiable risk factors for the development of
cardiovascular disease and type two diabetes mellitus. Knowing the current prevalence of …

Abstract Data from 6246 participants aged 20–64 years (2339 males and 3907 females) in
the cross-sectional phase of Tehran Lipid and Glucose Study (February 1999–May 2000) …

Background Diabetes is characterized by chronic hyperglycemia and disturbances of
carbohydrate, lipid and protein metabolism. We aimed to research association between …

Introduction Dyslipidemia may be defined as increased levels of serum total cholesterol
(TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), or a decreased serum …